Joshua Reed

Insider Reports History

Entity
Individual
Location
C/O Aldeyra Therapeutics, Inc., 131 Hartwell Avenue, Suite 320, Lexington, MA
Signature
/s/ Junlin Ho, Attorney-in-Fact for Joshua Reed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua Reed:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. Chief Financial Officer Common Stock 275K $478K $1.74 Mar 30, 2022 Direct
Scholar Rock Holding Corp Director Common Stock 13.5K $121K $8.99 Jun 27, 2024 Direct
Aldeyra Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 250K Mar 30, 2022 Direct
Omega Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 110K Feb 7, 2024 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 18K Jun 27, 2024 Direct

Insider Reports Filed by Joshua Reed

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRRK Scholar Rock Holding Corp Jun 27, 2024 2 $0 4 Jul 1, 2024 Director
OMGA Omega Therapeutics, Inc. Feb 7, 2024 1 $0 4 Feb 9, 2024 Chief Financial Officer
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
OMGA Omega Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 2, 2023 Chief Financial Officer
OMGA Omega Therapeutics, Inc. Oct 27, 2022 1 $0 4 Oct 28, 2022 Chief Financial Officer
OMGA Omega Therapeutics, Inc. May 31, 2022 1 $0 4 Jun 2, 2022 Chief Financial Officer
SRRK Scholar Rock Holding Corp May 26, 2022 1 $0 4 May 27, 2022 Director
OMGA Omega Therapeutics, Inc. May 23, 2022 0 $0 3 Jun 2, 2022 Chief Financial Officer
ALDX Aldeyra Therapeutics, Inc. Mar 30, 2022 2 $0 4 Apr 1, 2022 Chief Financial Officer